Valeant ups offer to acquire Obagi Medical
Valeant Pharmaceuticals International Inc. has increased its offer to purchase Obagi Medical Products after Merz Pharma Group made a larger bid for the company. Valeant and Obagi said Wednesday that under an amended agreement, Valeant raised its tender offer to acquire Obagi from $19.